Market Tracker

01/23 3:10am ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

110.14
Delayed Data
As of Jan 20
 -4.53 / -3.95%
Today’s Change
89.76
Today|||52-Week Range
177.93
+1.37%
Year-to-Date
3 Biotechs Likely to Be Acquired in 2017
Jan 22 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close114.67
Today’s open112.22
Day’s range108.62 - 113.84
Volume509,539
Average volume (3 months)484,561
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-63.63%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book4.64

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-1.16-1.66%
CBPOChina Biologic Produ...+0.43+0.40%
ENDPEndo International P...-0.56-4.34%
HZNPHorizon Pharma PLC-0.06-0.36%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$3.70
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer
Sandip Kapadia
Corporate headquarters
New York, New York

Forecasts